These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31665324)

  • 1. In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3).
    Presley BC; Logan BK; Jansen-Varnum SA
    J Anal Toxicol; 2020 Apr; 44(3):226-236. PubMed ID: 31665324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Identification of MDMB-CHMINACA Metabolites Using Zebrafish and Human Liver Microsomes as the Biotransformation System by LC-QE-HF-MS.
    Xu DQ; Dai Y; Zhang WF; Wang JF; Wang YY; Zhang Y; Zhao QL; Li X
    J Anal Toxicol; 2021 Jan; 44(9):1012-1026. PubMed ID: 32020177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
    Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
    Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I metabolism of synthetic cannabinoid receptor agonist PX-1 (5F-APP-PICA) via incubation with human liver microsomes and UHPLC-HRMS.
    Presley BC; Logan BK; Jansen-Varnum SA
    Biomed Chromatogr; 2020 Mar; 34(3):e4786. PubMed ID: 31863591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
    Carlier J; Diao X; Sempio C; Huestis MA
    AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry.
    Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
    Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8908. PubMed ID: 32710798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of the synthetic cannabinoids PX-1, PX-2, and PX-3 by high-resolution mass spectrometry and their clearance rates in human liver microsomes.
    Cooman T; Bell S
    Rapid Commun Mass Spectrom; 2019 Dec; 33(23):1816-1825. PubMed ID: 31364227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantification of predominant metabolites of synthetic cannabinoid MAB-CHMINACA in an authentic human urine specimen.
    Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Watanabe K; Suzuki O
    Drug Test Anal; 2018 Feb; 10(2):365-371. PubMed ID: 28560823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of an indazole-3-carboxamide class synthetic cannabinoid: 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid (DMBA-CHMINACA).
    Lee JH; Jung A; Park HN; Lee C; Mandava S; Lim SJ; Lim BB; Park SK; Lee J; Kang H
    Forensic Sci Int; 2018 Oct; 291():167-174. PubMed ID: 30216842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.
    Baginski SR; Rautio T; Nisbet LA; Lindbom K; Wu X; Dahlén J; McKenzie C; Gréen H
    J Anal Toxicol; 2023 Dec; 47(9):826-834. PubMed ID: 37747838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tentative identification of the metabolites of (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods.
    Grigoryev A; Kavanagh P; Labutin A; Pechnikov A; Dowling G; Shevyrin V; Krupina N
    Drug Test Anal; 2019 Sep; 11(9):1387-1402. PubMed ID: 31243890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of AB-CHMINACA and its metabolites in human hair and their deposition in hair of abusers.
    Sim J; Cho HS; Lee J; In S; Kim E
    J Pharm Biomed Anal; 2017 Jun; 140():162-168. PubMed ID: 28359963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.
    Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K
    Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of third generation synthetic cannabinoids using zebrafish larvae.
    Morales-Noé A; Esteve-Turrillas FA; Armenta S
    Drug Test Anal; 2022 Apr; 14(4):594-603. PubMed ID: 34750997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.